Talcum Powder Bellwether Trial in Federal MDL Expected to Begin in April 2022
The first talcum powder ovarian cancer bellwether trial has been scheduled to begin sometime in April 2022.…
«
»
The first talcum powder ovarian cancer bellwether trial has been scheduled to begin sometime in April 2022.…
Johnson & Johnson and major prescription drug distributors have agreed to a $26 billion settlement to resolve thousands of opioid crisis lawsuits.…
A class action lawsuit filed against Johnson & Johnson calls for restitution for consumers who purchased Neutrogena and Aveeno aerosol sunscreen products which were recently recalled for having high levels of benzene, which is a known cancer-causing agent.…
There are more than 360 Elmiron vision loss lawsuits filed in courts nationwide, as parties prepare for a hearing in September meant to explain the science behind the interstitial cystitis drug and its alleged adverse effects to a federal judge.…
A news report warns Johnson & Johnson may break off its talcum powder business into a separate company which will file bankruptcy, in order to shield the parent company from massive liability costs linked to cancer and asbestos lawsuits.…
A class action lawsuit claims Johnson & Johnson falsely advertises OGX shampoo and conditioner products as safe, despite containing chemicals which could cause hair loss, skin irritation and cancer.…
The FDA has added new label warnings to the Johnson & Johnson COVID-19 vaccine, indicating it may increase the risk of an autoimmune disorder known as Guillain–Barré syndrome.…
An Elmiron lawsuit filed by a West Virginia woman claims she suffered pigmentary maculopathy after nearly 10 years of using the bladder pain drug.…
A federal judge dismissed the Personal Care Products Council from ongoing talcum powder cancer litigation last week, saying the group had no legally responsible role in the marketing or sale of talc-based products.…
The first batch of federal talcum powder cases are being prepared for bellwether trials in 2022.…